HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The role of 111In-octreotide scintigraphy in the detection of APUD tumours: our experience in eighteen patients.

Abstract
111In-Octreotide scintigraphy has been recently proposed as a sensitive technique for the detection of neuroendocrine tumours, based on the high radiotracer affinity towards the somatostatin receptors expressed by the APUD-system cells. In the present study, a group of 18 patients with carcinoid tumours and gastrointestinal (GI) apudomas was investigated to assess the accuracy of Octreotide scintigraphy in localizing primitive, recurrent or metastatic lesions. Both planar and SPECT studies were obtained 4 hours after the i.v. injection of 111In-Octreotide (111 MBq); planar images were also carried out 24 hours later. In accordance with other authors, the sensitivity of the method was found to be very high (94%) in our group of patients; only in one case of nesidioblastosis was the scintigraphy negative. No differences in sensitivity were observed between the planar and SPECT studies, but the latter provided a better topographic localization of the neoplastic foci. It should be pointed out that in 7 cases (3 primitive, 1 recurrent and 3 metastatic lesions) scintigraphy correctly localized the tumour, when the other morphological techniques, such as echography, computed tomography or magnetic resonance, failed. On the basis of our data, we believe that Octreotide scintigraphy should be the first study performed in the evaluation of patients affected by APUD tumours.
AuthorsN Borsato, F Chierichetti, P Zanco, D Rubello, C Pasquali, S Pedrazzoli, G Ferlin
JournalThe quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) (Q J Nucl Med) Vol. 39 Issue 4 Suppl 1 Pg. 113-5 (Dec 1995) ISSN: 1125-0135 [Print] Italy
PMID9002766 (Publication Type: Journal Article)
Chemical References
  • Indium Radioisotopes
  • Radiopharmaceuticals
  • Receptors, Somatostatin
  • indium-111-octreotide
  • Octreotide
Topics
  • Angiography
  • Apudoma (diagnostic imaging, secondary)
  • Carcinoid Tumor (diagnostic imaging, secondary)
  • Follow-Up Studies
  • Gastrointestinal Neoplasms (diagnostic imaging)
  • Humans
  • Indium Radioisotopes (administration & dosage)
  • Injections, Intravenous
  • Magnetic Resonance Imaging
  • Neoplasm Recurrence, Local (diagnostic imaging)
  • Octreotide (administration & dosage, analogs & derivatives)
  • Pancreatic Diseases (diagnostic imaging)
  • Radiopharmaceuticals (administration & dosage)
  • Receptors, Somatostatin (analysis)
  • Sensitivity and Specificity
  • Tomography, Emission-Computed, Single-Photon
  • Tomography, X-Ray Computed
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: